However, positive effects of PDE-5 inhibitors and NO in improving gas-blood exchange function and vasodilators can improve quality of life in patients with COPD encourage us to make the prediction that vasodilators can be used in concert. Here, PDE5A is linked to chronic obstructive pulmonary disease.